I would say that of course I do believe there should be access for especially the more sympathetic communities here that I think have been waiting a long time for research. They should have both financial accessibility as well as physician oversight.
The one thing I would caution against in terms of price differential is we didn't see in the Colorado model that a lot of people stayed within the medical system due to the tax differential. I believe they were not there for medicinal purposes but essentially for the tax break. Because of that, I think we had a price incentive, essentially a buyer's discount. The part of that I regret is that those who were likely to become more addicted to the substance often went and got medical cards in order to buy it at a lower price.